1. Home
  2. AREC vs GLSI Comparison

AREC vs GLSI Comparison

Compare AREC & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Resources Corporation

AREC

American Resources Corporation

HOLD

Current Price

$3.14

Market Cap

317.5M

Sector

Energy

ML Signal

HOLD

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

HOLD

Current Price

$28.25

Market Cap

372.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AREC
GLSI
Founded
2013
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.5M
372.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AREC
GLSI
Price
$3.14
$28.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$6.50
$50.00
AVG Volume (30 Days)
3.3M
168.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$42,083.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$7.78
52 Week High
$7.11
$34.10

Technical Indicators

Market Signals
Indicator
AREC
GLSI
Relative Strength Index (RSI) 49.58 55.34
Support Level $3.02 $9.47
Resistance Level $3.30 $32.61
Average True Range (ATR) 0.26 2.29
MACD 0.02 -0.01
Stochastic Oscillator 65.87 89.12

Price Performance

Historical Comparison
AREC
GLSI

About AREC American Resources Corporation

American Resources Corp constructs and/or purchases and manages a chain of combined gasoline, diesel and natural gas (NG) fueling and service stations; construct conversion factories to convert NG to liquefied natural gas (LNG) and compressed natural gas (CNG); and construct conversion factories to retrofit vehicles currently using gasoline or diesel fuel to also run on NG in the United States and also to build a convenience store to serve its customers in each of its locations. Its segments are AIC focused on the extraction, processing, transportation, and distribution of coal for a variety of industries, with a focus on metallurgical quality coal to the steel industry; RLMT; and EMC.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

Share on Social Networks: